Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
... for the completion of its ONCONASE(R) rolling New Drug Application (NDA) submission. Decreased ... to complete the final sections of the ONCONASE rolling NDA. As the company has previously reported, the ... to estimate that the final components of the rolling NDA will be submitted by the end of 2008, and the ...Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
... for the completion of its ONCONASE(R) rolling New Drug Application ("NDA") submission. ... to complete the final sections of the ONCONASE rolling NDA. As the company has previously reported, the ... "We are moving forward with the completion of our rolling NDA and appreciate the support expressed by our ...Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
... Arpida Ltd. (SWX: ARPN) today reported that the rolling submission of the New Drug Application (NDA) for ... Drug Administration (FDA) to file the NDA in a rolling process. Using a 'rolling NDA' allows ... to file the NDA in an electronic format. Both the rolling NDA and the electronic format could potentially ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... FDA and the agency has approved Fast Track designation for the product. rolling review of the New Drug Application ("NDA") has started. Our core ... for the treatment of Gaucher disease. On July 30 Shire began the rolling submission of a NDA for velaglucerase alfa to treat patients with ...Alfacell Hires Advisors to Advance Strategic Alternatives
... president. "We continue to make progress on the completion of our rolling new drug application (NDA) and have undertaken this project in an effort ... mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical ...Arpida Announces Full Year 2007 Financial Results
... has further agreed to file the NDA in an electronic format. Both the rolling NDA and the electronic format could greatly facilitate the review process. The rolling submission of the NDA package got underway in 2007 and is expected to be ...Winter Park Home to World's Foremost Producers of Large-Scale Decontamination Equipment
... decontamination of both the interior and exterior of large assets such as airplanes, ambulances, emergency vehicles, police cars and hospital rolling stock, such as stretchers and wheel chairs, in less than two hours. Not only can AeroClave's system save billions of dollars in stopping the ...UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics
... structure is a two-dimensional honeycomb lattice of carbon atoms. Structurally, it is related to carbon nanotubes (tiny hollow tubes formed by rolling up sheets of graphene) and buckyballs (hollow carbon molecules that form a closed cage). ...Roche Announces Back-to-Basics Approach to Diabetes Care - Simpler is Better
... glucose levels, giving them greater control in their everyday battles against diabetes. As the world leader in diabetes diagnostics, Roche is rolling out the ACCU-CHEK Testing in Pairs and ACCU-CHEK 360-degree View tools as a way to help adults, children and teens manage their diabetes more easily ...DuPont Leader: Agriculture is Up to Global Productivity Challenge
... in agricultural productivity have been achieved by inventing and adopting new technologies and management practices in North America and Europe, then rolling them out to other countries," he said. "Progress has been made with this approach, but we must leverage science-based knowledge and ...NeoGenomics Announces Fourth Quarter and Full Year 2008 Financial Results
... 2008 was the second year in a row that we were able to grow our revenues by approximately 75% and we accomplished much during the year, including rolling out many new products, growing our sales force considerably and achieving near break-even in our cash flow from operations. Although our fourth ...Alfacell Provides ONCONASE(R) NDA Submission Update
... pre-NDA meeting with the U.S. Food and Drug Administration (FDA) to discuss the company's planned submission of the final components of the ONCONASE rolling New Drug Application (NDA) for the treatment of unresectable malignant mesothelioma (UMM) patients. At the pre-NDA meeting, the FDA provided ...EAU Technologies Receives Patent for Empowered Water(TM)
... application. Following that, we protect it as best as we can while we develop a realistic business model and find an industry partner to assist with rolling out the technology," said Wade Bradley, CEO of EAU Technologies, Inc. "Mold remediation proved very effective early on. As mold is a major cause of ...Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products
... 9. Sleep disorders. President & CEO, Richard Cowan, states, "We are certainly pleased at the speed in which our business model is rolling out. The potential market size for some of these products is obviously very large. When multiplied by the various categories and compounded by ...Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA
... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...China-Biotics, Inc. Reports First Quarter 2009 Financial Results
... said. ''We are pleased that we were able to begin achieving meaningful sales of our bulk additives to commercial customers. We are also working on rolling out new retail outlets as quickly as we can. Those outlets already open more than one year have demonstrated tremendous year-over-year sales growth, ...Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
... globally with net sales reaching $168.5 million in the second quarter, indicating expanding global demand for the brand. Based on a series of rolling launches worldwide, we expect to see additional growth opportunities for Nexavar, particularly for the treatment of liver cancer," said Tony Coles, ....A first in integrated nanowire sensor circuitry
... The Javey group has devised two printing methods, contact and roller. The roller method involves growing nanowires on the surface of a cylinder and rolling it across the application substrate, like painting with a paint roller. Contact printing involves growing nanowires on a flat substrate, ...Alfacell Receives NASDAQ Delisting Letter
... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
... 100 direct- sales stores and 1,000 franchised chain stores, which have a total customer base of over 10 million. ''We are excited to be rolling out one of our high-performance software solutions to support Tiens Group's wide-ranging global operations," said Mr. Adam Yan, eFuture's chairman ...Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
... million shares and warrants issued in conjunction with the private financing and just under two million incentive options available under a 10% rolling plan. None of the above securities have been or are expected to be registered under the United States Securities Act of 1933 and may not be offered ...Alfacell Receives NASDAQ Non-Compliance Notification
... completed Phase III clinical trials of ONCONASE in unresectable malignant mesothelioma and, in addition to ongoing efforts to complete the related rolling New Drug Application, Alfacell is currently planning for Phase II clinical trials in other oncology indications. For more information, visit ...Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
... INDIANAPOLIS, May 14 /PRNewswire-FirstCall/ -- Thousands of Eli Lilly and Company employees in nearly 50 nations are rolling up their sleeves today to help address local community needs in celebration of Lilly's first-ever Global Day of Service, possibly the largest ...Genzyme Provides Update on Myozyme(R) Manufacturing
... a separate biologics license application (BLA) to gain approval for Myozyme produced at the 2000L scale. The agency proposed that Genzyme initiate a rolling BLA review process by submitting results from the LOTS study. Genzyme expects the FDA to give the BLA priority review and to act on the application ...NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
... our days sales outstanding ("DSO") at December 31, 2007 was approximately 78 days, down from 81 days on September 30, 2007. By the end of January our rolling three months DSO had fallen to 71 days. As a result, we turned cash flow from operations positive in January and we should be cash flow from ...Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
... recent fiscal quarter," said Kuslima Shogen, Alfacell's chief executive officer. "We have made considerable progress towards the completion of our rolling NDA and we have entered into key partnerships to promote and prepare for the successful commercialization of ONCONASE(R)." Clinical Trials Update ...